Document is current
Any future updates will be listed below
-
Authors
Ledru, Nicolas https://orcid.org/0000-0002-9237-3634
Wilson, Parker C. https://orcid.org/0000-0001-8647-9662
Muto, Yoshiharu https://orcid.org/0000-0002-0358-9442
Yoshimura, Yasuhiro https://orcid.org/0000-0002-3320-9869
Wu, Haojia https://orcid.org/0000-0002-7866-2544
Li, Dian https://orcid.org/0000-0002-5374-7314
Asthana, Amish https://orcid.org/0000-0002-4597-5982
Tullius, Stefan G. https://orcid.org/0000-0003-3058-3166
Waikar, Sushrut S. https://orcid.org/0000-0003-4004-326X
Orlando, Giuseppe
Humphreys, Benjamin D. https://orcid.org/0000-0002-6420-8703
- License Information
-
More Information
Article History
Received: 20 January 2023
Accepted: 31 January 2024
First Online: 12 February 2024
Competing interests
: B.D.H. is a consultant for Janssen Research & Development, LLC, Pfizer and Chinook Therapeutics, holds equity in Chinook Therapeutics and grant funding from Janssen Research & Development, LLC and Pfizer; all interests are unrelated to the current work.
